Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.14 (Beat by $0.09) |
EPS GAAP Actual | $0.14 (Beat by $0.09) |
Revenue Actual | $0.398B |
Revenue Surprise | Beat by $398M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.44269 |
EPS GAAP Estimate | $0.44269 |
Revenue Estimate | $0.548816557B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.48667 | 5.02 | 3.38415 | 3.56552 | 1 |
Dec 2028 | 3.93 | 4.45 | 3.75521 | 4.222 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.08 | -0.08 | 0.398B | 0.75% | 398M |
FQ4 2024 (Dec 2024) | 0.0143 | 0.0143 | 0.411B | 5.11% | 411M |
FQ3 2024 (Sep 2024) | 0.67 | 0.67 | 0.532B | 100% | 532M |
FQ2 2024 (Jun 2024) | 0.17 | 0.17 | 0.497B | 100% | 497M |
FQ1 2024 (Mar 2024) | -0.43 | -0.43 | 0.395B | 100% | 395M |
FQ4 2023 (Dec 2023) | 0.23 | 0.23 | 0.39B | 9.23% | 390M |
FQ3 2023 (Sep 2023) | 0.73 | 0.73 | 0B | -INF% | 0M |
FQ2 2023 (Jun 2023) | 0.46 | 0.46 | 0B | -INF% | 0M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.44269
Consensus Revenue Estimates
0.548816557B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.64275 | -- | 0.60929 | 0.67212 | 2 |
FQ2 2027 (Jun 2027) | 0.6773 | -- | 0.64204 | 0.70825 | 2 |
FQ1 2027 (Mar 2027) | 0.002621 | -- | 0.00248456 | 0.00274075 | 2 |
FQ4 2026 (Oct 2026) | 0.80827 | -- | 0.76695 | 0.85497 | 9 |
FQ3 2026 (Jul 2026) | 0.57026 | -- | 0.54111 | 0.60321 | 9 |
FQ2 2026 (Jun 2026) | 0.77038 | -- | 0.74361 | 0.80456 | 4 |
FQ1 2026 (Mar 2026) | 0.26409 | 130.29 | 0.25491 | 0.27581 | 4 |
FQ4 2025 (Oct 2025) | 0.66898 | 97.86 | 0.63478 | 0.70763 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.64B | -- | 0.61B | 0.66B | 5 |
FQ2 2027 (Jun 2027) | 0.6B | -- | 0.57B | 0.62B | 4 |
FQ1 2027 (Mar 2027) | 0.42B | -- | 0.41B | 0.44B | 8 |
FQ4 2026 (Oct 2026) | 0.63B | -- | 0.61B | 0.66B | 10 |
FQ3 2026 (Jul 2026) | 0.57B | -- | 0.55B | 0.6B | 10 |
FQ2 2026 (Jun 2026) | 0.64B | -- | 0.63B | 0.67B | 10 |
FQ1 2026 (Mar 2026) | 0.45B | 11.73 | 0.44B | 0.47B | 10 |
FQ4 2025 (Oct 2025) | 0.6B | 31.99 | 0.58B | 0.63B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.08 | -0.08 | 100% | |
FQ4 2024 (Dec 2024) | 0.0143 | 0.0143 | 100% | |
FQ3 2024 (Sep 2024) | 0.67 | 0.67 | 100% | |
FQ2 2024 (Jun 2024) | 0.17 | 0.17 | 100% | |
FQ1 2024 (Mar 2024) | -0.43 | -0.43 | 100% | |
FQ4 2023 (Dec 2023) | 0.23 | 0.23 | 100% | |
FQ3 2023 (Sep 2023) | 0.73 | 0.73 | 100% | |
FQ2 2023 (Jun 2023) | 0.46 | 0.46 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.4B | $398M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.41B | $411M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.53B | $532M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.5B | $497M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.4B | $395M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.39B | $390M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |
FQ2 2023 (Jun 2023) | $0B | $0B | $0M | NAN% |